Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study.

Saved in:
Bibliographic Details
Title: Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study.
Authors: Gossec, Laure1,2 (AUTHOR), Bouguen, Guillaume3 (AUTHOR), Dellal, Azeddine4 (AUTHOR), Foulley, Lucile5 (AUTHOR), Habauzit, Caroline5 (AUTHOR) Caroline.Habauzit@celltrionhc.com, Benkhalifa, Salim5 (AUTHOR), Marotte, Hubert6 (AUTHOR)
Source: Rheumatology & Therapy. Jun2026, Vol. 13 Issue 3, p645-658. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21986576
DOI:10.1007/s40744-026-00840-7